KuhnARulandVBonsmannG. Photosensitivity, phototesting, and photoprotection in cutaneous lupus erythematosus. Lupus2010; 19: 1036–1046.
2.
ScheinfeldNDeleoVA. Photosensitivity in lupus erythematosus. Photodermatol Photoimmunol Photomed2004; 20: 272–279.
3.
BourgaudFHehnALarbatR. Biosynthesis of coumarins in plants: a major pathway still to be unravelled for cytochrome P450 enzymes. Phytochemistry Reviews2006; 5: 293–308.
4.
BaskinJMLudlowCJHarrisTMWolfFT. Psoralen, an inhibitor in the seeds of Psoralea subacaulis Leguminosae. Phytochemistry1967; 6: 1209–1213.
5.
BeierRC. Natural pesticides and bioactive components in foods. Rev Environ Contam Toxicol1990; 113: 47–137.
6.
BeierRCOertliEH. Psoralen and other linear furocoumarins as phytoalexins in celery. Phytochemistry1983; 22: 2595–2597.
7.
GasparroFPLiaoBFoleyPJWangXMMcNiffJM. Psoralen photochemotherapy, clinical efficacy, and photomutagenicity: the role of molecular epidemiology in minimizing risks. Environ Mol Mutagen1998; 31: 105–112.
8.
SternRSBolshakovSNatarajAJAnanthaswamyHN. p53 mutation in nonmelanoma skin cancers occurring in psoralen ultraviolet a-treated patients: evidence for heterogeneity and field cancerization. J Invest Dermatol2002; 119: 522–526.
9.
Dall AAcquaFVedaldiDRecherM. The photoreaction between furoccoumarins and various DNA with different base components. Photochem Photobiol1978; 27: 33–36.
10.
BerenbaumM. Herbivores: Their Interactions with Secondary Plant MetabolitesSan Diego: Academic Press, 1991.
11.
KanervaLElsnerPWahlbergJMaibachH. Condensed Handbook of Occupational DermatologyNew York: Springer, 2004.
12.
AbramowitzAIResnikKSCohenKR. Margarita photodermatitis. N Engl J Med1993; 328: 891–891.
13.
BeattiePEWilkieMJSmithGFergusonJIbbotsonSH. Can dietary furanocoumarin ingestion enhance the erythemal response during high-dose UVA1 therapy?J Am Acad Dermatol2007; 56: 84–87.
14.
LemboGLoPMBalatoN. Phytophotodermatitis due to ficus carica. Photodermatol1985; 2: 119–120.
15.
LjunggrenB. Severe phototoxic burn following celery ingestion. Arch Dermatol1990; 126: 1334–1336.
16.
SchlatterJZimmerliBDickRPanizzonRSchlatterC. Dietary intake and risk assessment of phototoxic furocoumarins in humans. Food Chem Toxicol1991; 29: 523–530.
17.
WatembergNUrkinYWitztumA. Phytophotodermatitis due to figs. Cutis1991; 48: 151–152.
18.
DijkstraJWChangL. Severe phototoxic burn following celery ingestion. Arch Dermatol1992; 128: 1277–1277.
19.
SongPSTapleyKJJr. Photochemistry and photobiology of psoralens. Photochem Photobiol1979; 29: 1177–1197.
20.
BickersDRPathakMA. Psoralen pharmacology: studies on metabolism and enzyme induction. Natl Cancer Inst Monogr1984; 66: 77–84.
21.
BillardVGambusPLBarrJ. The pharmacokinetics of 8-methoxypsoralen following i.v. administration in humans. Br J Clin Pharmacol1995; 40: 347–360.
22.
HerfstMJde WolffFA. Influenced of food on the kinetics of 8-methoxypsoralen in serum and suction blister fluid in psoriatic patients. Eur J Clin Pharmacol1982; 23: 75–80.
23.
KornhauserAWamerWGGilesALJr. Difference in topical and systemic reactivity of psoralens: determinations of epidermal and serum levels. Natl Cancer Inst Monogr1984; 66: 97–101.
24.
SchmidJProxAZippHKossFW. The use of stable isotopes to prove the saturable first-pass effect of methoxsalen. Biomed Mass Spectrom1980; 7: 560–564.
25.
EhrssonHWallinIRosAMEksborgSBergM. Food-induced increase in bioavailability of 5-methoxypsoralen. Eur J Clin Pharmacol1994; 46: 375–377.
26.
StolkLMSiddiquiAH. Biopharmaceutics, pharmacokinetics and pharmacology of psoralens. Gen Pharmacol1988; 19: 649–653.
27.
WaltherTHausteinUF. [8-MOP serum level profile following administration of Geroxalen to patients with psoriasis and a control group]. Dermatol Monatsschr1990; 176: 313–316.
28.
Bech-ThomsenNAngeloHRKnudsenEA. The influence of food on 8-methoxypsoralen serum concentration and minimal phototoxic dose. Br J Dermatol1992; 127: 620–624.
29.
Studer-SachsenbergEMPilettaPAFathiMSauratJHSalomonD. Influence of metoclopramide on the pharmacokinetics of 8-methoxypsoralen. Dermatology1997; 195: 81–83.
30.
GouldJWMercurioMGElmetsCA. Cutaneous photosensitivity diseases induced by exogenous agents. J Am Acad Dermatol1995; 33: 551–573.
31.
MurphyGM. Investigation of photosensitive disorders. Photodermatol Photoimmunol Photomed2004; 20: 305–311.
32.
GronhagenCMGunnarssonISvenungssonENybergF. Cutaneous manifestations and serological findings in 260 patients with systemic lupus erythematosus. Lupus2010; 19: 1187–1194.
33.
WysenbeekAJBlockDAFriesJF. Prevalence and expression of photosensitivity in systemic lupus erythematosus. Ann Rheum Dis1989; 48: 461–463.
34.
LehmannPHolzleEKindPGoerzGPlewigG. Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation. J Am Acad Dermatol1990; 22: 181–187.
35.
DourmishevLMeffertHPiazenaH. Dermatomyositis: comparative studies of cutaneous photosensitivity in lupus erythematosus and normal subjects. Photodermatol Photoimmunol Photomed2004; 20: 230–234.
36.
BultinkIETurkstraFDiamantMDijkmansBAVoskuylAE. Prevalence of and risk factors for the metabolic syndrome in women with systemic lupus erythematosus. Clin Exp Rheumatol2008; 26: 32–38.
37.
MayorAMVilaLMDe LaCMGomezR. Impact of managed care on clinical outcome of systemic lupus erythematosus in Puerto Rico. J Clin Rheumatol2003; 9: 25–32.
38.
TektonidouMGSotsiouFMoutsopoulosHM. Antiphospholipid syndrome APS. nephropathy in catastrophic, primary, and systemic lupus erythematosus-related APS. J Rheumatol2008; 35: 1983–1988.
39.
ArjumandSAliA. Cross-reactions of human lupus autoantibodies with 8-methoxypsoralen photomodified DNA fragments. Microbiol Immunol1994; 38: 239–243.
40.
DomkeHFLudwigsenEThormannJ. Discoid lupus erythematosus possibly due to photochemotherapy. Arch Dermatol1979; 115: 642–642.
41.
EyansonSGreistMCBrandtKDSkinnerB. Systemic lupus erythematosus: association with psoralen–ultraviolet-A treatment of psoriasis. Arch Dermatol1979; 115: 54–56.
42.
SternRSMorisonWLThibodeauLA. Antinuclear antibodies and oral methoxsalen photochemotherapy PUVA for psoriasis. Arch Dermatol1979; 115: 1320–1324.
43.
WagstaffDJ. Dietary exposure to furocoumarins. Regulatory Toxicology and Pharmacology1991; 14: 261–272.
44.
ChaudharySKCeskaOWarringtonPJAshwood-SmithMJ. Increased furocoumarin content of celery during storage. J Agric Food Chem1985; 33: 1153–1157.
45.
OstertagEBeckerTAmmonJBauer-AymannsHSchrenkD. Effects of storage conditions on furocoumarin levels in intact, chopped, or homogenized parsnips. J Agric Food Chem2002; 50: 2565–2570.
46.
TrumbleJTDercksWQuirosCFBeierRC. Host plant resistance and linear furanocoumarin content of Apium accessions. J Econ Entomol1990; 83: 519–525.
47.
FlemingD. Dermatitis in grocery workers associated with high natural concentrations of furanocoumarins in celery. Allergy Proc1990; 11: 125–127.
48.
GorgusELohrCRaquetNGuthSSchrenkD. Limettin and furocoumarins in beverages containing citrus juices or extracts. Food Chem Toxicol2010; 48: 93–98.
49.
UesawaYMohriK. The use of heat treatment to eliminate drug interactions due to grapefruit juice. Biol Pharm Bull2006; 29: 2274–2278.
50.
IvieGWHoltDLIveyMC. Natural toxicants in human foods: Psoralens in raw and cooked parsnip root. Science1981; 213: 909–910.
51.
BrillSZimmermannCBergerKDreweJGutmannH. In vitro interactions with repeated grapefruit juice administration – to peel or not to peel?Planta Med2009; 75: 332–335.
52.
MyungKNarcisoJAMantheyJA. Removal of furanocoumarins in grapefruit juice by edible fungi. J Agric Food Chem2008; 56: 12064–12068.
53.
NeogiTChenCChaissonCHunterDZhangY. Short-term effects of caffeinated beverage intake on risk of recurrent gout attacks. Arthritis Rheum2010; 62: 1362–1362.
54.
ZhangYChenCHunterDChaissonCChoiHNeogiT. Cherry consumption and risk of recurrent gout attacks. Arthritis Rheum2010; 62: 1366–1366.
55.
WangGPierangeliSSPapalardoEAnsariGAKhanMF. Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity. Arthritis Rheum2010; 62: 2064–2072.
56.
ForsbergLdeFUMorgensternR. Oxidative stress, human genetic variation, and disease. Arch Biochem Biophys2001; 389: 84–93.
57.
MiaoLSt ClairDK. Regulation of superoxide dismutase genes: implications in disease. Free Radic Biol Med2009; 47: 344–356.
58.
SzetoYTTongHH. Caffeine as a photoprotective agent for diminishing phototoxicity. Toxicol Ind Health2010; 26: 667–670.
59.
SelvaagEPetersenABGniadeckiRThornTWulfHC. Phototoxicity to diuretics and antidiabetics in the cultured keratinocyte cell line HaCaT: evaluation by clonogenic assay and single cell gel electrophoresis Comet assay. Photodermatol Photoimmunol Photomed2002; 18: 90–95.
60.
ReeKRugstadHEBakkaA. Ultrastructural changes in the nucleus of a human epithelial cell line exposed to cytotoxic agents. The effect of PUVA and cadmium. Acta Pathol Microbiol Immunol Scand A1982; 90: 427–435.
61.
GuoLQYamazoeY. Inhibition of cytochrome P450 by furanocoumarins in grapefruit juice and herbal medicines. Acta Pharmacol Sin2004; 25: 129–136.
62.
MurrayM. Altered CYP expression and function in response to dietary factors: potential roles in disease pathogenesis. Curr Drug Metab2006; 7: 67–81.